Top Stories
-
As part of the Biden Administration's Cancer Moonshot initiative, First Lady Jill Biden and Queen Letizia of Spain visited Columbia University's cancer center on Sept. 21.
Topic
-
Jill Biden and Queen Letizia learned about the cancer center's work to transform care, improve diversity and access in clinical trials, and promote diversity and inclusion in science and medicine.
-
The symposium will feature keynotes by Margaret Foti, chief executive at AACR, and Ned Sharpless, former director of the NCI, along with talks from leading members of the cancer center.
Topic
-
Columbia researchers have found that a protein released by multiple myeloma cells prevents the immune system from attacking the cancer, a finding that could lead to better treatments.
Latest News
- May 12, 2014
Two genes together drive the most lethal forms of prostate cancer; could lead to diagnostic test and new treatments.
Topic
- April 18, 2014
New bone marrow transplant unit specializes in cutting-edge treatments for blood cancers and autoimmune diseases.
Topic
- April 9, 2014
Important tips on sunglasses and sun exposure from NewYork-Presbyterian Hospital experts.
Topic
- April 3, 2014
Alfred Neugut, MD, PhD, says it may be time to make aspirin a part of the conventional standard of care for colon cancer.
Topic
- March 26, 2014
Early detection of retinoblastoma in children does not improve outcomes, suggests a Mailman study.
Topic
- March 12, 2014
This patient-focused event will highlight the latest advances in the screening, diagnosis, and treatment of colorectal cancer.
Topic
- February 20, 2014
The American Medical Association has honored P&S student Gregory Joice for his research.
Topic
- January 23, 2014
Breast cancer study in mice suggests that radiation therapy to unaffected breast could reduce risk of second cancer.
Topic
- January 21, 2014
Common type of leukemia may start with a change in bone cells.
Topic
- January 6, 2014
NewYork-Presbyterian/Columbia University Medical Center has named leading physician-scientist Dr. Gary Schwartz chief of the Division of Hematology/Oncology in the Department of Medicine and associate director for research of its Herbert Irving Comprehensive Cancer Center.
Topic
